Explorations on Death
How do we live with our own mortality? How do we encounter the reality that we must die? Michael Lerner explores these and other questions.
. First published on : Oct 27 2023The Mystery of What Follows Death
Healing into life and awareness of our mortality are not opposites. They are two sides of the same coin.
. Last modified on : Oct 27 2023Visits with My Dead
Hundreds of people, especially Cancer Help Program alumni, have told me similar stories of friends and family who have appeared to them as they died, or were about to die, or after they died.
. Last modified on : Oct 27 2023New Efforts to Make Cell Therapies Like CAR-T More Accessible for Patients
Cell therapies like CAR-T are an extraordinary new class of drugs that have the potential to successfully treat cancer.
. Last modified on : Jan 25 2025Healing and Curing
In Choices In Healing: Integrating the Best of Conventional and Complementary Approaches to Cancer, Michael Lerner describes both healing and curing cancer, suggesting how they differ and how they relate to each other. This post draws from the second chapter of his book.
. Last modified on : Mar 03 20247 Lifestyle Practices: Being Active in Your Cancer Treatment and Outcomes
Did you know that being active in your wellness by building practices and habits can improve your outcomes with conventional cancer treatments such as chemotherapy, surgery, and immunotherapy?
. Last modified on : Dec 23 2023How to Evaluate Trustworthiness of Websites on Complementary Cancer Therapies
How can you tell the sites with supportable claims from those that are less trustworthy?
. Last modified on : Dec 23 2023The Evidence House: Valuing What the Physician Sees in Practice
Interpreting study results involves assessing the trade-offs between highly controlled situations and relevance to real life, then using the evidence that makes the most sense in the situation.
. Last modified on : Dec 27 2023Why Randomized Controlled Trials Don’t Always Tell the Real-World Story
RCTs are not always the best approach to get definitive answers to clinical questions.
. Last modified on : Nov 05 2024Complementary Therapies and Cancer: How Much Evidence Is Enough?
We view the use of science-informed, low-risk, affordable therapies as a reasonable option for patients. Stronger evidence of benefit is needed for therapies that are risky, expensive, or otherwise burdensome.
. Last modified on : Dec 27 2023